ArticleCancers2025

Proposed Refinement of 2022 European LeukemiaNet Adverse-Risk Group of AML Patients Using a Real-World Cohort.

Collins Wangulu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.